Viper ULTRA Thrombolysis Catheter
אן ultra infusion catheter specialized for direct thrombolytic delivery, featuring multi-hole design to uniformly distribute drugs across large clot segments.
ה Viper® Ultrasonic Pharmacomechanical Thrombolysis System הוא זעיר פולשני device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin ו increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications ו preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.
Ultrasonic Wave Delivery
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
Pharmacomechanical Infusion
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
Gentle Mechanization
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
מפרט מוצר
מִפרָט | פירוט / ערך |
שם המוצר | Viper ULTRA Thrombolysis Catheter |
שימוש מיועד | Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial) |
עיצוב קטטר | Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip |
חוֹמֶר | Pebax/Polyamide shaft, potentially braided or reinforced |
קוטר חיצוני (F) | ~4–6F (depending on infusion lumen capacity) |
אורך עבודה | ~80–150 cm (varies by product code) |
Infusion Ports | Distributed side ports over a defined segment for consistent thrombolytic delivery |
תאימות חוטי הנחיה | Typically 0.014” or 0.018” |
עֲקָרוּת | סטרילי, לשימוש חד פעמי |
חיי מדף | ~2–3 years if stored at 15–25 °C in sealed packaging |
אינדיקציות קליניות | Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis |
התוויות נגד | Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies |
מטריצת הזמנות וגודל
קוטר חיצוני (F) | אורך עבודה (ס"מ) | Infusion Segment (cm) | קוד מוצר | הערות |
4F | 80 | 10 | VPR-4F-80-10 | Smaller OD for distal or small vessel usage |
4F | 120 | 15 | VPR-4F-120-15 | Longer shaft, moderate infusion segment |
5F | 80 | 10 | VPR-5F-80-10 | Slightly larger OD for heavier clot load |
5F | 120 | 20 | VPR-5F-120-20 | Extended length with longer infusion zone |
6F | 100 | 15 | VPR-6F-100-15 | Common size for multi-level peripheral lesions |
6F | 150 | 30 | VPR-6F-150-30 | Max length, extensive infusion segment |